david gfeller
Université de Lausanne
H-index: 44
Europe-Switzerland
Top articles of david gfeller
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Semi-supervised integration of single-cell transcriptomics data | Nature Communications | Massimo Andreatta Léonard Hérault Paul Gueguen David Gfeller Ariel J Berenstein | 2024/1/29 |
Building and analyzing metacells in single-cell genomics data | bioRxiv | Mariia Bilous Léonard Hérault Aurélie AG Gabriel Matei Teleman David Gfeller | 2024 |
Deep learning predictions of TCR-epitope interactions reveal epitope-specific chains in dual alpha T cells | Nature Communications | Giancarlo Croce Sara Bobisse Dana Léa Moreno Julien Schmidt Philippe Guillame | 2024/4/13 |
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes | Immunity | Julien Racle Philippe Guillaume Julien Schmidt Justine Michaux Amédé Larabi | 2023/6/13 |
Contemplating immunopeptidomes to better predict them | David Gfeller Yan Liu Julien Racle | 2023/3/1 | |
Improved predictions of antigen presentation and TCR recognition with MixMHCpred2. 2 and PRIME2. 0 reveal potent SARS-CoV-2 CD8+ T-cell epitopes | Cell Systems | David Gfeller Julien Schmidt Giancarlo Croce Philippe Guillaume Sara Bobisse | 2023/1/18 |
Robust estimation of cancer and immune cell-type proportions from bulk tumor ATAC-Seq data | bioRxiv | Aurelie AG Gabriel Julien Racle Maryline Falquet Camilla Jandus David Gfeller | 2023/10/14 |
The MHC Motif Atlas: a database of MHC binding specificities and ligands | Nucleic Acids Research | Daniel M Tadros Simon Eggenschwiler Julien Racle David Gfeller | 2023/1/6 |
A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer | Nature Cancer | Sara Bobisse Valentina Bianchi Janos L Tanyi Apostolos Sarivalasis Edoardo Missiaglia | 2023/10 |
How to predict binding specificity and ligands for new MHC-II alleles with MixMHC2pred | bioRxiv | Julien Racle David Gfeller | 2023 |
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors | Nature Communications | Julien Schmidt Johanna Chiffelle Marta AS Perez Morgane Magnin Sara Bobisse | 2023/6/6 |
MECHANISMS OF RESISTANCE TO CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IN MULTIPLE MYELOMA | Marco Ruella Felix Korell Patrizia Porazzi Marcela V Maus | 2023/12 | |
Metacells untangle large and complex single-cell transcriptome networks | BMC bioinformatics | Mariia Bilous Loc Tran Chiara Cianciaruso Aurélie Gabriel Hugo Michel | 2022/8/13 |
Both APRIL and antibody-fragment-based CAR T cells for myeloma induce BCMA downmodulation by trogocytosis and internalization | Journal for Immunotherapy of Cancer | Nicolas Camviel Benita Wolf Giancarlo Croce David Gfeller Vincent Zoete | 2022 |
Rapid BCMA downmodulation on myeloma cells upon CAR T cell contact is mediated by trogocytosis and BCMA internalization | bioRxiv | Nicolas Camviel Benita Wolf Giancarlo Croce David Gfeller Vincent Zoete | 2022/7/24 |
Predictions of immunogenicity reveal potent SARS-CoV-2 CD8+ T-cell epitopes | bioRxiv | David Gfeller Julien Schmidt Giancarlo Croce Philippe Guillaume Sara Bobisse | 2022/5/23 |
Deciphering the landscape of phosphorylated HLA-II ligands | Iscience | Marthe Solleder Julien Racle Philippe Guillaume George Coukos Michal Bassani-Sternberg | 2022/5/20 |
Sensitive identification of neoantigens and cognate TCRs in human solid tumors | Nature biotechnology | Marion Arnaud Johanna Chiffelle Raphael Genolet Blanca Navarro Rodrigo Marta AS Perez | 2022/5 |
182P Cancer vaccines based on whole-tumor-lysate or neoepitopes with validated HLA-binding outperform those with predicted HLA-binding affinity | Immuno-Oncology and Technology | L Kandalaft H Fritah M Graciotti C Chiang R Petremand | 2022/12/1 |
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting | Cell Reports Medicine | Julien Schmidt Angela R Smith Morgane Magnin Julien Racle Jason R Devlin | 2021/2/16 |
Co-Authors
